Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

SIOG 2016 /
Multiple myeloma in the elderly

17th - 19th Nov 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 22.11.16
Views: 1366

Prof Tanya Wildes - Washington University School of Medicine, St. Louis, USA

Prof Wildes meets with ecancertv at SIOG 2016 to discuss treating multiple myeloma in elderly patients.

She describes how an aggressive course of treatment is not always the best regimen, especially in the geriatric setting, and references clinical trials establishing maintenance therapy as more tolerable overall.

Prof Wildes considers how this might inform treatment guidelines, and the place of immunotherapy in future care programs.

This service has been kindly supported by an unrestricted grant from Merck/MSD.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation